<i>TARDBP</i> mutations in motoneuron disease with frontotemporal lobar degeneration
Lina Benajiba(Inserm), Alexis Brice(Inserm), Isabelle Le Ber(Inserm), Eric Guedj(Centre de Résonance Magnétique Biologique et Médicale), Philippe Couratier(Centre Hospitalier Universitaire de Limoges), Vincent Meininger(Sorbonne Université), Didier Hannequin(Hôpital Charles-Nicolle), Lucette Lacomblez(Sorbonne Université), François Salachas(Sorbonne Université), Dominique Campion(Inserm), William Camu(Hôpital Gui de Chauliac), Solenn Legallic, Agnès Camuzat(Inserm), Bruno Dubois(Université de Lille), Mathieu Lacoste(Centre Hospitalier Universitaire de Limoges), Véronique Golfier(Centre Hospitalier Universitaire de Rennes), Catherine Thomas-Antérion(Bellevue Hospital Center), M. Décousus(Bellevue Hospital Center)
Cited by 302
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Analysis of shared heritability in common disorders of the brain
|Science|2018|2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k